Rankings
▼
Calendar
VRCA
Verrica Pharmaceuticals Inc.
$59M
Q4 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$1M
Net Income
-$1M
EPS (Diluted)
$-0.72
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$2M
Free Cash Flow
-$2M
Stock-Based Comp.
$79,000
Balance Sheet
Total Assets
$9M
Total Liabilities
$16M
Stockholders' Equity
-$7M
Cash & Equivalents
$9M
← FY 2017
All Quarters
Q1 2018 →
VRCA Q4 2017 Earnings — Verrica Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena
